A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT02760485 · COMPLETED
Trial details
- NCT number
- NCT02760485
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-29
- Primary completion
- 2022-06-06
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.